The biocompatibility of silver and nanohydroxyapatite coatings on titanium dental implants with human primary osteoblast cells.


Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 25 02 2019
revised: 30 08 2019
accepted: 16 09 2019
entrez: 26 11 2019
pubmed: 26 11 2019
medline: 16 4 2020
Statut: ppublish

Résumé

Silver nanoparticles (Ag NPs) are antimicrobial, with potential uses in medical implants, but Ag NPs alone can also be toxic to mammalian cells. This study aimed to enhance the biocompatibility of Ag NP-coated titanium dental implants with hydroxyapatite (HA) applied to the surface. Ti6Al4V discs were coated with Ag NPs, Ag NPs plus HA nanoparticles (Ag + nHA), or Ag NPs plus HA microparticles (Ag + mHA). The stability of coatings was explored and the biocompatibility with primary human osteoblasts over 7 days. Results showed that Ti6Al4V discs were successfully coated with silver and HA. The primary particle size of nHA and mHA were 23.90 ± 1.49 nm and 4.72 ± 0.38 μm respectively. Metal analysis showed that underlying silver coatings remain stable in DMEM culture media, but the presence of FBS in the media caused some initial (clinically beneficial) release of dissolved silver. With additions of HA, osteoblasts were adherent, had normal morphology, negligible lactate dehydrogenase (LDH) leak, and showed alkaline phosphatase (ALP) activity. Cell viability was around 70% throughout the Ag + nHA treatment. Overall, the implants coated with Ag + nHA maintained a higher degree of biocompatibility compared to those coated with Ag + mHA, or Ag NPs alone, suggesting the former has a benefit for clinical use.

Identifiants

pubmed: 31761164
pii: S0928-4931(19)30746-5
doi: 10.1016/j.msec.2019.110210
pii:
doi:

Substances chimiques

Alloys 0
Coated Materials, Biocompatible 0
Dental Implants 0
titanium alloy (TiAl6V4) 12743-70-3
Silver 3M4G523W1G
Durapatite 91D9GV0Z28
Titanium D1JT611TNE
Alkaline Phosphatase EC 3.1.3.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110210

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Ranj Nadhim Salaie (RN)

School of Biological and Marine Sciences, Faculty of Science and Engineering, University of Plymouth, UK; Plymouth University Peninsula Schools of Medicine and Dentistry, University of Plymouth, UK.

Alexandros Besinis (A)

School of Biological and Marine Sciences, Faculty of Science and Engineering, University of Plymouth, UK; School of Engineering, Faculty of Science and Engineering, University of Plymouth, UK; Plymouth University Peninsula Schools of Medicine and Dentistry, University of Plymouth, UK.

Huirong Le (H)

School of Mechanical Engineering and Built Environment, College of Engineering and Technology, University of Derby, UK.

Christopher Tredwin (C)

Plymouth University Peninsula Schools of Medicine and Dentistry, University of Plymouth, UK.

Richard D Handy (RD)

School of Biological and Marine Sciences, Faculty of Science and Engineering, University of Plymouth, UK; Visiting Professor, Department of Nutrition, Cihan University-Erbil, Kurdistan Region, Iraq. Electronic address: r.handy@plymouth.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH